Stock Earnings

Question 1

IDEAYA Biosciences Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, IDEAYA Biosciences Inc'in toplam varlıkları $1,124 olup, net loss $-274'dir.

Question 2

IDYA'ün temel finansal oranları nelerdir?

Accepted Answer

IDEAYA Biosciences Inc'in cari oranı 17.56, net kâr marjı -3,914.28, hisse başına satış $0.08'dir.

Question 3

IDEAYA Biosciences Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

IDEAYA Biosciences Inc largest revenue segment is Oncology-focused Precision Medicine, at a revenue of 7,000,000 in the most earnings release.For geography, United States is the primary market for IDEAYA Biosciences Inc, at a revenue of 7,000,000.

Question 4

IDEAYA Biosciences Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre IDEAYA Biosciences Inc'in net loss $-274'dir.

Question 5

IDEAYA Biosciences Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, IDEAYA Biosciences Inc'in yükümlülüğü 64'dir.

Question 6

IDEAYA Biosciences Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

IDEAYA Biosciences Inc'in toplam tedavüldeki hisse sayısı 86.5'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	7	7	23	50	27	19
Revenue Growth (YoY)	-36%	-70%	-54%	85%	42%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	49	39	28	23	20	15
Research & Development	--	294	129	89	58	39
Operating Expenses	391	333	157	113	78	54
Other Non Operating Income (Expenses)	53	--	--	--	--	--
Pretax Income	-331	-274	-112	-58	-49	-34
Income Tax Expense	0	0	--	--	--	--
Net Income	-331	-274	-112	-58	-49	-34
Net Income Growth	115.99%	145%	93%	18%	44%	-17%
Shares Outstanding (Diluted)	88	81.67	57.51	41.44	35.25	24.72
Shares Change (YoY)	13%	42%	39%	18%	43%	98%
EPS (Diluted)	-3.76	-3.36	-1.96	-1.42	-1.41	-1.4
EPS Growth	91%	71%	38%	1%	1%	-57.99%
Free Cash Flow	-296	-251	-117	-90	-58	54
Free Cash Flow Per Share	-3.36	-3.07	-2.03	-2.17	-1.64	2.18
Gross Margin	--	--	--	--	--	--
Operating Margin	-5,485.71%	-4,657.14%	-582.6%	-124%	-185.18%	-184.21%
Profit Margin	-4,728.57%	-3,914.28%	-486.95%	-115.99%	-181.48%	-178.94%
Free Cash Flow Margin	-4,228.57%	-3,585.71%	-508.69%	-180%	-214.81%	284.21%
EBITDA	-382	-324	-132	-60	-49	-34
EBITDA Margin	-5,457.14%	-4,628.57%	-573.91%	-120%	-181.48%	-178.94%
D&A For EBITDA	2	2	2	2	1	1
EBIT	-384	-326	-134	-62	-50	-35
EBIT Margin	-5,485.71%	-4,657.14%	-582.6%	-124%	-185.18%	-184.21%
Effective Tax Rate	0%	0%	--	--	--	--

IDEAYA Biosciences Inc (IDYA) Price

IDYA Stock Price Chart

IDYA Income

Follow-Up Questions